{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:57:31Z","timestamp":1761919051556,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2687,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.bbmt.2007.09.004","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T17:09:44Z","timestamp":1196096984000},"page":"1499-1507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Comparable Outcomes after Nonmyeloablative Hematopoietic Cell Transplantation with Unrelated and Related Donors"],"prefix":"10.1016","volume":"13","author":[{"given":"Marco","family":"Mielcarek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry E.","family":"Storer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda M.","family":"Sandmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed L.","family":"Sorror","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effie","family":"Petersdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Storb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.09.004_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1034\/j.1399-0039.2003.00096.x","article-title":"Maximizing optimal hematopoietic stem cell donor selection from registries of unrelated adult volunteers","volume":"61","author":"Hurley","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2007.09.004_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM198509263131301","article-title":"Marrow transplantation from related donors other than HLA-identical siblings","volume":"313","author":"Beatty","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2007.09.004_bib3","first-page":"2993","article-title":"Marrow transplantation from unrelated HLA-matched volunteer donors","volume":"21","author":"Beatty","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2007.09.004_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199002223220801","article-title":"Successful allogeneic transplantation of T-cell\u2013depleted bone marrow from closely HLA-matched unrelated donors","volume":"322","author":"Ash","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.09.004_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-119-3-199308010-00005","article-title":"Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: a comparison of complications in the first 2 years","volume":"119","author":"Marks","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.09.004_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.1994.tb04979.x","article-title":"Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors","volume":"88","author":"Schiller","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.09.004_bib7","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood.V86.3.1228.1228","article-title":"The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone","volume":"86","author":"Nademanee","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib8","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V92.10.3515","article-title":"Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient","volume":"92","author":"Petersdorf","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib9","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood.V89.5.1818","article-title":"Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors","volume":"89","author":"Petersdorf","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood.V86.4.1606.bloodjournal8641606","article-title":"The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, and DR identical unrelated donor marrow transplantation","volume":"86","author":"Petersdorf","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib11","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1182\/blood.V87.10.4455.bloodjournal87104455","article-title":"High-resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation","volume":"87","author":"Speiser","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib12","first-page":"649","article-title":"Transplant registries: guiding clinical decisions and improving outcomes","volume":"15","author":"Horowitz","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.bbmt.2007.09.004_bib13","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","article-title":"Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects","volume":"97","author":"McSweeney","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"issue":"Part 1","key":"10.1016\/j.bbmt.2007.09.004_bib15","first-page":"742a","article-title":"Nonmyeloablative hematopoietic stem cell transplants (HSCT) from HLA-matched related donors for patients with hematologic malignancies: clinical results of a TBI-based conditioning regimen","volume":"98","author":"Sandmaier","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib16","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","article-title":"Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality","volume":"98","author":"Khouri","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","article-title":"Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation","volume":"97","author":"Giralt","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","article-title":"Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplant comorbidities","volume":"104","author":"Sorror","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.V99.3.1071","article-title":"Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen","volume":"99","author":"Chakraverty","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib20","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib21","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1172\/JCI4285","article-title":"Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease","volume":"102","author":"Cooke","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2007.09.004_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.175.2.405","article-title":"Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor \u03b1 during graft-versus-host disease","volume":"175","author":"Nestel","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2007.09.004_bib24","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V83.8.2360.2360","article-title":"Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H2-incompatible transplanted SCID mice","volume":"83","author":"Xun","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib25","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1182\/blood.V88.12.4601.bloodjournal88124601","article-title":"Mechanism for cotolerance in nonlethally conditioned mixed chimeras: negative selection of the V\u03b2 T-cell receptor repertoire by both host and donor bone marrow\u2013derived cells","volume":"88","author":"Colson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00007890-199807150-00015","article-title":"Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen","volume":"66","author":"Manilay","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.09.004_bib27","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2003-02-0482","article-title":"HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies","volume":"102","author":"Maris","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib28","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","article-title":"Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses","volume":"94","author":"Childs","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2141.2005.05458.x","article-title":"Prognostic relevance of \u201cearly-onset\u201d graft-versus-host disease following nonmyeloablative hematopoietic cell transplantation","volume":"129","author":"Mielcarek","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.09.004_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbmt.2003.10.006","article-title":"Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation","volume":"10","author":"Couriel","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.004_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbmt.2005.12.030","article-title":"Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing","volume":"12","author":"Maris","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.004_bib33","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","article-title":"Morbidity and mortality with nonmyeloablative compared to myeloablative conditioning before hematopoietic cell transplantation from HLA- matched related donors","volume":"104","author":"Diaconescu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib34","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib35","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2007-03-078592","article-title":"Relapse risk among patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"11","author":"Kahl","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure times in the presence of competing risks","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"key":"10.1016\/j.bbmt.2007.09.004_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0021-9681(82)90058-3","article-title":"Adjusted survival curve estimation using covariates","volume":"35","author":"Makuch","year":"1982","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.bbmt.2007.09.004_bib38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V99.6.1971","article-title":"Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation","volume":"99","author":"Weisdorf","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-144-6-200603210-00007","article-title":"A risk score for mortality after allogeneic hematopoietic cell transplantation","volume":"144","author":"Parimon","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.09.004_bib40","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2004-04-1674","article-title":"Limits of HLA mismatching in unrelated hematopoietic cell transplantation","volume":"104","author":"Petersdorf","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib41","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.09.004_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bbmt.2007.01.073","article-title":"Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia","volume":"13","author":"Moore","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.09.004_bib43","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1056\/NEJM199804023381405","article-title":"Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia","volume":"338","author":"Hansen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.09.004_bib44","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood-2002-09-2866","article-title":"Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors","volume":"102","author":"Ottinger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.09.004_bib45","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","volume":"24","author":"Yakoub-Agha","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.09.004_bib46","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.2004.07.130","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission","volume":"22","author":"Kiehl","year":"2004","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107004417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107004417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:30:06Z","timestamp":1761057006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107004417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1083879107004417"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.09.004","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparable Outcomes after Nonmyeloablative Hematopoietic Cell Transplantation with Unrelated and Related Donors","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}